Pharmesis International Balance Sheet Health
Financial Health criteria checks 3/6
Pharmesis International has a total shareholder equity of CN¥52.8M and total debt of CN¥15.0M, which brings its debt-to-equity ratio to 28.4%. Its total assets and total liabilities are CN¥78.9M and CN¥26.1M respectively.
Key information
28.4%
Debt to equity ratio
CN¥15.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥3.44m |
| Equity | CN¥52.78m |
| Total liabilities | CN¥26.11m |
| Total assets | CN¥78.89m |
Financial Position Analysis
Short Term Liabilities: BFK's short term assets (CN¥27.2M) exceed its short term liabilities (CN¥25.3M).
Long Term Liabilities: BFK's short term assets (CN¥27.2M) exceed its long term liabilities (CN¥861.0K).
Debt to Equity History and Analysis
Debt Level: BFK's net debt to equity ratio (21.9%) is considered satisfactory.
Reducing Debt: BFK's debt to equity ratio has increased from 19.4% to 28.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BFK has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BFK has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18% each year